CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
3.150
-0.030 (-0.94%)
Feb 19, 2026, 9:54 AM EST - Market open
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $1.95 million as of February 19, 2026. Its market cap has decreased by -72.59% in one year.
Market Cap
1.95M
Enterprise Value
-7.86M
1-Year Change
-72.59%
Ranking
Category
Stock Price
$3.15
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $1.95M, a decrease of -97.21%. That is a compound annual growth rate of -43.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 2.02M | -37.90% |
| Dec 31, 2025 | 3.26M | -52.95% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scinai Immunotherapeutics | 2.58M |
| BioRestorative Therapies | 2.53M |
| CDT Equity | 2.49M |
| Lyra Therapeutics | 2.47M |
| Artelo Biosciences | 2.42M |
| Cardio Diagnostics Holdings | 2.32M |
| Azitra | 2.15M |
| Bone Biologics | 2.14M |